Objective: To evaluate percutaneous treatment options for preserving hemodialysis access after angioplasty-related venous rupture, we retrospectively reviewed the charts for all dialysis access angioplasties performed over a 33-month period. Seven cases of venous rupture after venous angioplasty were identified (four men and three women; mean age, 63.5 years). Treatment included observation only (n = 1), a second prolonged balloon inflation at the rupture site (n = 2), stent insertion (n = 5), and manual graft occlusion (n = 1). Treatment was successful in eliminating contrast extravasation in all patients while maintaining immediate graft function in six out of seven patients. None of the patients required emergent surgical intervention. The mean primary and secondary patency rates of the salvaged grafts after intervention were 2.3 and 9.3 months, respectively. Five of seven access sites were still patent at the most recent follow-up.

Conclusion: Prolonged balloon inflation or placement of a stent may salvage hemodialysis access in most patients after angioplasty-related venous rupture. Primary and secondary patency have proven to be satisfactory.

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.171.4.9763001DOI Listing

Publication Analysis

Top Keywords

venous rupture
16
hemodialysis access
12
percutaneous treatment
8
angioplasty-related venous
8
prolonged balloon
8
balloon inflation
8
primary secondary
8
secondary patency
8
venous
5
access
5

Similar Publications

Skeletal muscle relaxants have their place in everyday use in numerous anesthesiological procedures, such as preparing a patient for surgery, supporting mechanical ventilation, and performing effective intubation. These drugs can be divided, based on their mechanism of action, into depolarizing skeletal relaxants, such as succinylcholine, and non-depolarizing skeletal muscle relaxants. Non-depolarizing agents are further categorized, based on their structure, into steroidal (eg, rocuronium) and benzylisoquinoline (eg, atracurium) compounds.

View Article and Find Full Text PDF

Coronary microembolization (CME) is defined as atherosclerotic plaque erosion, spontaneous rupture, or rupture of the plaque while undergoing interventional therapy resulting in the formation of tiny emboli that obstruct the coronary microcirculatory system. For percutaneous coronary intervention, CME is a major complication, with a periprocedural incidence of up to 25%. Recent studies have demonstrated that regulatory cell death (RCD) exerts a profound influence on CME through its modulation of inflammatory responses, oxidative stress, cell death, and angiogenesis.

View Article and Find Full Text PDF

The Natural History of Portal Venous System Aneurysms.

J Vasc Surg Venous Lymphat Disord

December 2024

Division of Vascular Surgery, UPMC, Pittsburgh, Pennsylvania; Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address:

Background: Portal venous system aneurysms (PVA) are increasingly diagnosed on cross-sectional computed tomography (CT) imaging. However, the natural history of these aneurysms is poorly understood and reports are limited to small case series.

Methods: Terms relevant to PVA were searched in radiology reports (2010-2022) with PVA presence confirmed by manual review.

View Article and Find Full Text PDF
Article Synopsis
  • This study used computational fluid dynamics (CFD) to explore how blood flow dynamics in the draining veins of arteriovenous malformations (AVMs) relate to whether they rupture or not.
  • Researchers analyzed data from computed tomography angiography (CTA) and found that while the shape of the veins was similar in ruptured and unruptured cases, ruptured AVMs had significantly higher intravascular pressure and wall shear stress (WSS) in specific vein segments.
  • The findings suggest that ruptured AVMs are associated with higher blood flow velocity and pressure, particularly in the posterior segments of the draining veins, which may help in understanding AVM rupture mechanisms.
View Article and Find Full Text PDF

This is an annual report indicating the number and early clinical results of annual vascular treatment performed by vascular surgeons in Japan in 2017, as analyzed by Database Management Committee (DBC) members of the Japanese Society for Vascular Surgery (JSVS). To survey the current status of vascular treatments performed by vascular surgeons in Japan, the DBC members of the JSVS analyzed the vascular treatment data provided by the National Clinical Database, including the number of treatments and early results such as operative and hospital mortality. In total, 137,909 vascular treatments were registered by 1,076 institutions in 2017.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!